Stent thrombosis after percutaneous coronary intervention: from bare-metal to the last generation of drug-eluting stents

A Polimeni, S Sorrentino, C Spaccarotella… - Cardiology …, 2020 - cardiology.theclinics.com
… but harmful complication of percutaneous coronary implantation (… comparing sirolimus-eluting
stents with bare-metal stents. … for bleeding undergoing percutaneous coronary intervention. …

[HTML][HTML] Coronary stent thrombosis—predictors and prevention

H Ullrich, T Muenzel, T Gori - Deutsches Ärzteblatt International, 2020 - ncbi.nlm.nih.gov
bleeding in order to reduce hemorrhagic complications, discontinuation in this context appears
to be safer following implantation … ) compared a sirolimus-eluting stent (60-µm stent strut …

Sirolimus release from biodegradable polymers for coronary stent application: A review

W Xu, M Sasaki, T Niidome - Pharmaceutics, 2022 - mdpi.com
… between the sirolimus-eluting stents and everolimus-eluting stents [… bleeding. According to
five-year clinical outcomes, Nobori presents lower risks of cardiac death and stent thrombosis

Real-world dual antiplatelet therapy following polymer-free sirolimus-eluting stent implantations to treat coronary artery disease

F Krackhardt, M Waliszewski, V Kočka… - … drugs and therapy, 2020 - Springer
… ), stent thrombosis (ST), and bleeding events. A logistic regression was utilized to determine
predictors why ticagrelor was used in stable coronaryrisks for ischemic events and bleeding

Drug-eluting stent thrombosis: current and future perspectives

S Kuramitsu, S Sonoda, K Ando, H Otake… - Cardiovascular …, 2021 - Springer
complications than those with ACS originating from de novo … performed after restoring
coronary flow. Moreover, radiologic … with a higher thrombotic risk against their bleeding risk [76]. …

… procedure (CHIP) and high-bleeding-risk (HBR) patients undergoing percutaneous coronary intervention with sirolimus-eluting stent implantation: 4-year results

M Tyczyński, A Kern, P Buller, W Wańha… - Journal of Clinical …, 2023 - mdpi.com
… increased rates of recurrent MI or definite stent thrombosis compared to BMSs. Up to 48 …
complications. Regarding periprocedural complications, we should not forget about bleeding

Clinical outcomes of the dual-therapy CD34 antibody-covered sirolimus-eluting stent versus standard drug-eluting coronary stents: a meta-analysis

P Ndunda, MR Vindhyal, T Muutu, Z Fanari - Cardiovascular …, 2020 - Elsevier
… risk of 1-year definite stent thrombosis is up to 1.3% in some studies [6]. Stent thrombosis is
… % [2,7] and therefore, there is a need for innovative solutions to prevent DES complications. …

[HTML][HTML] Real-world experience with a tapered biodegradable polymer-coated sirolimus-eluting stent in patients with long coronary artery stenoses

A Lupi, F Ugo, L De Martino, V Infantino… - Cardiology …, 2020 - ncbi.nlm.nih.gov
… ), and failure occurred without stent detachment or other complications. Final TIMI3 flow was
… for non-cardiac causes. During the hospital stay, no patient suffered from stent thrombosis, …

Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence

F Condello, C Spaccarotella, S Sorrentino… - Journal of clinical …, 2023 - mdpi.com
… in Brazil implanted the first sirolimus-eluting stent, which … time of implantation and local
blood rheology after implantation, … of a sirolimus-eluting stent with a standard stent for coronary

Healing and stent coverage with the new ultrathin sirolimuseluting stent with abluminal biodegradable polymer

EJ Jun, SP Hong, B Kim, JB Lee… - Catheterization and …, 2023 - Wiley Online Library
… treatment of coronary artery disease. Concerns over late stent thrombosis associated with …
of DAPT, reducing the risk of bleeding complications. Proper neointimal formation and a lower …